Javaid M, Song F, Leinster S, Dickson M G, James N K
Department of Plastic and Reconstructive Surgery, Lister Hospital Stevenage and School of Medicine, Health Policy and Practice University of East Anglia, Norwich NR4 7TJ, UK.
J Plast Reconstr Aesthet Surg. 2006;59(1):16-26. doi: 10.1016/j.bjps.2005.07.007.
To conduct a systematic review to gather the available evidence on the optimum timing of the radiotherapy in relation to autologous breast reconstruction.
The data was extracted from scientific databases, and a manual follow-up of references. The studies were selected which included at least 20 patients with any method of autologous breast reconstruction who were treated with adjuvant radiotherapy either before or after their reconstruction, and had addressed the effects of radiotherapy on the cosmetic outcome in their results. The principal outcome was cosmetic appearance. Secondary outcomes were immediate and delayed complications.
We could not find any randomised controlled trial on this topic. Ten studies were included, most were retrospective, heterogeneous in terms of control groups, radiation doses, follow-up duration, and outcome measurements. Two studies included no control groups, and four studies compared the outcomes of patients with radiotherapy either before (n=3) or after (n=1) autologous breast reconstruction. The overall incidence of complications was increased in patients with radiotherapy in three out of these four studies. Only four studies directly compared the outcomes of patients who received radiotherapy before with patients who received radiotherapy after autologous breast reconstruction and two out of these reported worse outcomes associated with post-reconstruction radiotherapy.
Despite the paucity of the published data, the current evidence suggests that the radiation has a deleterious effect on autologous flap reconstruction. Until better methods of radiation delivery can be devised to minimise the long term radiation sequelae in the irradiated tissue, delayed reconstruction seems to be a safe option in most of the cases. However, the findings from these studies should be interpreted with great caution before generalising from their results.
进行一项系统评价,以收集关于自体乳房重建放疗最佳时机的现有证据。
从科学数据库中提取数据,并对手参考文献进行追踪。纳入的研究需包括至少20例采用任何自体乳房重建方法的患者,这些患者在重建前或重建后接受辅助放疗,且研究结果中涉及放疗对美容效果的影响。主要结局为美容外观。次要结局为即刻和延迟并发症。
我们未找到关于该主题的任何随机对照试验。纳入了10项研究,大多数为回顾性研究,在对照组、辐射剂量、随访时间和结局测量方面存在异质性。两项研究未设对照组,四项研究比较了自体乳房重建前(n = 3)或后(n = 1)接受放疗患者的结局。在这四项研究中的三项中,接受放疗患者的并发症总发生率有所增加。只有四项研究直接比较了自体乳房重建前接受放疗患者与重建后接受放疗患者的结局,其中两项报告称重建后放疗的结局较差。
尽管已发表的数据较少,但目前的证据表明放疗对自体皮瓣重建有有害影响。在能够设计出更好的放疗方法以尽量减少受照射组织的长期放疗后遗症之前,延迟重建在大多数情况下似乎是一个安全的选择。然而,在从这些研究结果进行推广之前,应非常谨慎地解释这些研究结果。